M.D. Anderson Cancer Center: Gastrointestinal Neoplasms trials

The registry lists 25 Gastrointestinal Neoplasms studies with M.D. Anderson Cancer Center as lead sponsor. 4 are open to participants now and 7 have results posted.

Phase 1 4Phase 2 8Phase 3 3No phase 11(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Goals of Care Discussion for Patients With Advanced Lung and Gastrointestinal Cancer in the Emergency Department of a Comprehensive Cancer CenterRecruitingNCT06420206Not applicable
• Molecular Epidemiology of Biliary Tree CancersRecruitingNCT05179486
• Evaluation of Portal Vein Stenting in Patients With Portal Vein Stenosis and Gastrointestinal CancersRecruitingNCT04629677
• Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton TherapyRecruitingNCT00991094
• Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) for Metastatic Gastric CancerCompletedNCT02092298Phase 2Results posted
• Abraxane in CIMP-High Colorectal and Small Bowel AdenocarcinomasCompletedNCT01730586Phase 2Results posted
• A Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation TherapyCompletedNCT01624220Not applicableResults posted
• CAPOX in KRAS Wild-Type Advanced Adenocarcinoma of the Small Bowel or Ampulla of VaterCompletedNCT01202409Phase 2Results posted
• Trial of a Sustained Release Methylphenidate in the Treatment of Fatigue in Cancer PatientsTerminatedNCT00516269Phase 3Results posted
• Melatonin Versus Placebo and the Effect on Appetite in Advanced Cancer PatientsCompletedNCT00513357Phase 3Results posted
• Capecitabine and Oxaliplatin in Adenocarcinoma of the Small Bowel and Ampulla of VaterCompletedNCT00354887Phase 2Results posted
• A Phase I Study of Adagrasib and Durvalumab for Treatment of Advanced Non-small Cell Lung Cancers and Gastro-intestinal Cancers Harboring KRAS G12C MutationsWithdrawnNCT05848843Phase 1
• Sleep Disturbances in Surgical Patients With GI Cancers: A Quantitative and Qualitative AnalysisWithdrawnNCT05044312Not applicable
• Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse EventsActive, not recruitingNCT05038254Not applicable
• Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal CordActive, not recruitingNCT02713269Phase 2
• Massage Therapy in Reducing Chemotherapy-Induced Peripheral Neuropathy in Patients With Gastrointestinal or Breast MalignanciesActive, not recruitingNCT02221700Not applicable
• Crossover Trial of Systemic Chemotherapy in Patients With Metastatic Well-Differentiated Mucinous Appendiceal Adenocarcinomas With Pseudomyxoma PeritoneiActive, not recruitingNCT01946854Not applicable
• Tasigna Neoadjuvant Gastrointestinal Stromal Tumor (GIST)WithdrawnNCT01270893Phase 2
• Rocking Motion: Physiologic Effect on the Surgical Stress ResponseCompletedNCT01200316Phase 1
• Validating M.D. Anderson Symptom Inventory (MDASI-GI) in GI Cancer Patients Under ChemotherapyCompletedNCT00849979Not applicable
• Evaluation of a Novel CT-On-Rails or Trilogy Stereotactic Spine Radiotherapy System (SSRS)Active, not recruitingNCT00508443Phase 1/2
• Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal CancerCompletedNCT00436657Phase 1
• Irinotecan and Cisplatin for High Grade Neuroendocrine Carcinoma of the Gastrointestinal TractCompletedNCT00353015Phase 2
• A Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of Weekly Procrit Given to Gastric or Rectal PatientsTerminatedNCT00254436Phase 3
• Mindfulness Relaxation Compared With Relaxing Music and Standard Symptom Management Education in Treating Patients Who Are Undergoing Chemotherapy For Newly Diagnosed Solid TumorsCompletedNCT00086762Not applicable